CNC-bZIP Protein Nrf1-Dependent Regulation of Glucose-Stimulated Insulin Secretion

Antioxidants and Redox Signaling

Volumn 22, Issue 10, 2015, Pages 819-831

  Zheng, Hongzhi ^a,b   Fu, Jingqi ^a,b   Xue, Peng ^b,c   Zhao, Rui ^a   Dong, Jian ^b,d   Liu, Dianxin ^e   Yamamoto, Masayuki ^f   Tong, Qingchun ^g   Teng, Weiping ^a   Qu, Weidong ^c   Zhang, Qiang ^b   Andersen, Melvin E ^b   Pi, Jingbo ^a,b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^c FUDAN UNIVERSITY   (China)

^d WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e BURNHAM INSTITUTE   (United States)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; GLUCOKINASE; GLUCOSE; GLUCOSE TRANSPORTER 2; GLUTATHIONE; GLUTATHIONE DISULFIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEXOKINASE 1; INSULIN; LACTATE DEHYDROGENASE; MESSENGER RNA; NUCLEAR RESPIRATORY FACTOR 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN KINASE B; PROTEIN P53; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR NRF1; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; NRF1 PROTEIN, MOUSE;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL METABOLISM; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; GENE SILENCING; GENOTYPE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HYPERINSULINEMIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RELEASE; MALE; MIN6 CELL LINE; MITOCHONDRIAL RESPIRATION; MOLECULAR WEIGHT; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; UPREGULATION; WHITE ADIPOSE TISSUE; ANIMAL; CELL LINE; GENETICS; HYPERINSULINISM; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; SECRETION (PROCESS); TRANSGENIC MOUSE;

MUS;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CELL LINE; GLUCOSE; HYPERINSULINISM; INSULIN; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOCHONDRIA; NUCLEAR RESPIRATORY FACTOR 1; OXIDATIVE STRESS;

EID: 84925003359     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6017     Document Type: Article

References (50)

1. Ainscow EK, Zhao C, and Rutter GA. Acute overexpression of lactate dehydrogenase-A perturbs beta-cell mitochondrial metabolism and insulin secretion. Diabetes 49: 1149-1155, 2000.
2. Ashcroft FM and Rorsman P. Diabetes mellitus and the beta cell: the last ten years. Cell 148: 1160-1171, 2012.
3. Back SH and Kaufman RJ. Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem 81: 767-793, 2012.
4. Becker TC, BeltrandelRio H, Noel RJ, Johnson JH, and Newgard CB. Overexpression of hexokinase I in isolated islets of Langerhans via recombinant adenovirus. Enhancement of glucose metabolism and insulin secretion at basal but not stimulatory glucose levels. J Biol Chem 269: 21234-21238, 1994.
5. Becker TC, Noel RJ, Johnson JH, Lynch RM, Hirose H, Tokuyama Y, Bell GI, and Newgard CB. Differential effects of overexpressed glucokinase and hexokinase I in isolated islets. Evidence for functional segregation of the high and low Km enzymes. J Biol Chem 271: 390-394, 1996.
6. Biswas M and Chan JY. Role of Nrf1 in antioxidant response element-mediated gene expression and beyond. Toxicol Appl Pharmacol 244: 16-20, 2010.
7. Buettner C. Is hyperinsulinemia required to develop overeating-induced obesity? Cell Metab 16: 691-692, 2012.
8. Chan JY, Kwong M, Lu R, Chang J, Wang B, Yen TS, and Kan YW. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J 17: 1779-1787, 1998.
9. Corkey BE. Banting lecture 2011: hyperinsulinemia: cause or consequence? Diabetes 61: 4-13, 2012.
10. Costes S, Huang CJ, Gurlo T, Daval M, Matveyenko AV, Rizza RA, Butler AE, and Butler PC. Beta-cell dysfunctional ERAD/ubiquitin/proteasome system in type 2 diabetes mediated by islet amyloid polypeptide-induced UCH-L1 deficiency. Diabetes 60: 227-238, 2011.
11. Donath MY, Boni-Schnetzler M, Ellingsgaard H, and Ehses JA. Islet inflammation impairs the pancreatic beta-cell in type 2 diabetes. Physiology (Bethesda) 24: 325-331, 2009.
12. Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E, and Reinecke M. Mechanisms of {beta}-cell death in type 2 diabetes. Diabetes 54 Suppl 2: S108-S113, 2005.
13. Fu J, Woods CG, Yehuda-Shnaidman E, Zhang Q, Wong V, Collins S, Sun G, Andersen ME, and Pi J. Low-level arsenic impairs glucose-stimulated insulin secretion in pancreatic beta cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118: 864-870, 2011.
14. Hartley T, Brumell J, and Volchuk A. Emerging roles for the ubiquitin-proteasome systemand autophagy in pancreatic beta-cells. Am J Physiol Endocrinol Metab 296: E1-E10, 2009.
15. Henquin JC. Pathways in beta-cell stimulus-secretion coupling as targets for therapeutic insulin secretagogues. Diabetes 53 Suppl 3: S48-S58, 2004.
16. Henquin JC. The dual control of insulin secretion by glucose involves triggering and amplifying pathways in beta-cells. Diabetes Res Clin Pract 93 Suppl 1: S27-S31, 2011.
17. Henquin JC. Do Pancreatic beta cells "Taste" nutrients to secrete insulin? Sci Signal 5: pe36, 2012.
18. Henquin JC, Ravier MA, Nenquin M, Jonas JC, and Gilon P. Hierarchy of the beta-cell signals controlling insulin secretion. Eur J Clin Invest 33: 742-750, 2003.
19. Hirotsu Y, Hataya N, Katsuoka F, and Yamamoto M. NF-E2-related factor 1 (Nrf1) serves as a novel regulator of hepatic lipid metabolism through regulation of the Lipin1 and PGC-1beta genes. Mol Cell Biol 32: 2760-2770, 2012.
20. Kim J, Xing W, Wergedal J, Chan JY, and Mohan S. Targeted disruption of nuclear factor erythroid-derived 2-like 1 in osteoblasts reduces bone size and bone formation in mice. Physiol Genomics 40: 100-110, 2010.
21. Kobayashi A, Tsukide T, Miyasaka T, Morita T, Mizoroki T, Saito Y, Ihara Y, Takashima A, Noguchi N, Fukamizu A, Hirotsu Y, Ohtsuji M, Katsuoka F, and Yamamoto M. Central nervous system-specific deletion of transcription factor Nrf1 causes progressive motor neuronal dysfunction. Genes Cells 16: 692-703, 2011.
22. Kong D, Tong Q, Ye C, Koda S, Fuller PM, Krashes MJ, Vong L, Ray RS, Olson DP, and Lowell BB. GABAergic RIP-Cre neurons in the arcuate nucleus selectively regulate energy expenditure. Cell 151: 645-657, 2012.
23. Kwong EK, Kim KM, Penalosa PJ, and Chan JY. Characterization of Nrf1b, a novel isoform of the nuclear factor-erythroid-2 related transcription factor-1 that activates antioxidant response element-regulated genes. PLoS One 7: e48404, 2012.
24. Kwong M, Kan YW, and Chan JY. The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J Biol Chem 274: 37491-37498, 1999.
25. Lee CS, Lee C, Hu T, Nguyen JM, Zhang J, Martin MV, Vawter MP, Huang EJ, and Chan JY. Loss of nuclear factor E2-related factor 1 in the brain leads to dysregulation of proteasome gene expression and neurodegeneration. Proc Natl Acad Sci U S A 108: 8408-8413, 2011.
26. Lee JY, Ristow M, Lin X, White MF, Magnuson MA, and Hennighausen L. RIP-Cre revisited, evidence for impairments of pancreatic beta-cell function. J Biol Chem 281: 2649-2653, 2006.
27. Levine AJ and Puzio-Kuter AM. The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes. Science 330: 1340-1344, 2010.
28. Lowell BB and Shulman GI. Mitochondrial dysfunction and type 2 diabetes. Science 307: 384-387, 2005.
29. Magnuson MA and Osipovich AB. Pancreas-specific Cre driver lines and considerations for their prudent use. Cell Metab 18: 9-20, 2013.
30. Maiztegui B, Borelli MI, Massa ML, Del Zotto H, and Gagliardino JJ. Enhanced expression of hexokinase I in pancreatic islets induced by sucrose administration. J Endocrinol 189: 311-317, 2006.
31. Malmgren S, Nicholls DG, Taneera J, Bacos K, Koeck T, Tamaddon A, Wibom R, Groop L, Ling C, Mulder H, and Sharoyko VV. Tight coupling between glucose and mitochondrial metabolism in clonal beta-cells is required for robust insulin secretion. JBiol Chem 284: 32395-32404, 2009.
32. Mehran AE, Templeman NM, Brigidi GS, Lim GE, Chu KY, Hu X, Botezelli JD, Asadi A, Hoffman BG, Kieffer TJ, Bamji SX, Clee SM, and Johnson JD. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metab 16: 723-737, 2012.
33. Ohtsuji M, Katsuoka F, Kobayashi A, Aburatani H, Hayes JD, and Yamamoto M. Nrf1 and Nrf2 play distinct roles in activation of antioxidant response element-dependent genes. J Biol Chem 283: 33554-33562, 2008.
34. Pi J, Bai Y, Daniel KW, Liu D, Lyght O, Edelstein D, Brownlee M, Corkey BE, and Collins S. Persistent oxidative stress due to absence of uncoupling protein 2 associated with impaired pancreatic beta-cell function. Endocrinology 150: 3040-3048, 2009.
35. Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE, and Collins S. Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56: 1783-1791, 2007.
36. Prentki M and Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812, 2006.
37. Radhakrishnan SK, Lee CS, Young P, Beskow A, Chan JY, and Deshaies RJ. Transcription factor Nrf1 mediates the proteasome recovery pathway after proteasome inhibition in mammalian cells. Mol Cell 38: 17-28, 2010.
38. Robertson RP. Oxidative stress and impaired insulin secretion in type 2 diabetes. Curr Opin Pharmacol 6: 615-619, 2006.
39. Schuit F, Van Lommel L, Granvik M, Goyvaerts L, de Faudeur G, Schraenen A, and Lemaire K. Beta-cell-specific gene repression: a mechanism to protect against inappropriate or maladjusted insulin secretion? Diabetes 61: 969-975, 2012.
40. Steffen J, Seeger M, Koch A, and Kruger E. Proteasomal degradation is transcriptionally controlled by TCF11 via an ERAD-dependent feedback loop. Mol Cell 40: 147-158, 2010.
41. Stumvoll M, Goldstein BJ, and van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365: 1333-1346, 2005.
42. Wang W, Kwok AM, and Chan JY. The p65 isoform of Nrf1 is a dominant negative inhibitor of ARE-mediated transcription. J Biol Chem 282: 24670-24678, 2007.
43. Wicksteed B, Brissova M, Yan W, Opland DM, Plank JL, Reinert RB, Dickson LM, Tamarina NA, Philipson LH, Shostak A, Bernal-Mizrachi E, Elghazi L, Roe MW, Labosky PA, Myers MG, Jr., Gannon M, Powers AC, and Dempsey PJ. Conditional gene targeting in mouse pancreatic ss-cells: analysis of ectopic Cre transgene expression in the brain. Diabetes 59: 3090-3098, 2010.
44. Xu Z, Chen L, Leung L, Yen TS, Lee C, and Chan JY. Liver-specific inactivation of the Nrf1 gene in adult mouse leads to nonalcoholic steatohepatitis and hepatic neoplasia. Proc Natl Acad Sci U S A 102: 4120-4125, 2005.
45. Xue P, Hou Y, Chen Y, Yang B, Fu J, Zheng H, Yarborough K, Woods CG, Liu D, Yamamoto M, Zhang Q, Andersen ME, and Pi J. Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome. Diabetes 62: 845-854, 2013.
46. Xue P, Hou Y, Zhang Q, Woods CG, Yarborough K, Liu H, Sun G, Andersen ME, and Pi J. Prolonged inorganic arsenite exposure suppresses insulin-stimulated AKT S473 phosphorylation and glucose uptake in 3T3-L1 adipocytes: Involvement of the adaptive antioxidant response. Biochem Biophys Res Commun 407: 360-365, 2011.
47. Zhang Y and Hayes JD. The membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity. Sci Rep 3: 2006, 2013.
48. Zhang Y, Lucocq JM, Yamamoto M, and Hayes JD. The NHB1 (N-terminal homology box 1) sequence in transcription factor Nrf1 is required to anchor it to the endoplasmic reticulum and also to enable its asparagine-glycosylation. Biochem J 408: 161-172, 2007.
49. Zhao R, Hou Y, Xue P, Woods CG, Fu J, Feng B, Guan D, Sun G, Chan JY, Waalkes MP, Andersen ME, and Pi J. Long isoforms of NRF1 contribute to arsenic-induced antioxidant response in human keratinocytes. Environ Health Perspect 119: 56-62, 2011.
50. Zhao R, Hou Y, Zhang Q, Woods CG, Xue P, Fu J, Yarborough K, Guan D, Andersen ME, and Pi J. Cross-regulations among NRFs and KEAP1 and effects of their silencing on arsenic-induced antioxidant response and cytotoxicity in human keratinocytes. Environ Health Perspect 120: 583-589, 2012.